Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 11, 2017
Dysregulation of energy metabolism in multiple sclerosis measured in vivo with diffusion-weighted spectroscopyBenedetta Bodini, Francesca Branzoli, Emilie Poirion, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|January 10, 2022
Automated Acquisition Planning for Magnetic Resonance Spectroscopy in Brain CancerPatrick J Bolan, Francesca Branzoli, Anna Luisa Di Stefano, et al.
Neuro-Oncology|February 7, 2019
Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopyFrancesca Branzoli, Clément Pontoizeau, Lucien Tchara, et al.
Neuro-Oncology|November 11, 2017
Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopyFrancesca Branzoli, Anna Luisa Di Stefano, Laurent Capelle, et al.
Frontiers in Neuroscience|December 25, 2023
Practical considerations of diffusion-weighted MRS with ultra-strong diffusion gradientsChristopher W Davies-Jenkins, André Döring, Fabrizio Fasano, et al.
Brain : a Journal of Neurology|March 13, 2016
Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolitesEce Ercan, Cesar Magro-Checa, Romain Valabregue, et al.
NMR in Biomedicine|January 22, 2021
Inflammation-driven glial alterations in the cuprizone mouse model probed with diffusion-weighted magnetic resonance spectroscopy at 11.7 TGuglielmo Genovese, Marco Palombo, Mathieu D Santin, et al.
NMR in Biomedicine|August 7, 2026
Diagnostic Accuracy of APTw and NOEw MRI Metrics for IDH Mutation and 1p/19q Codeletion Prediction in GliomasCapucine Cadin, Stefano Casagranda, François Xavier Lejeune, et al.
Endocrine-Related Cancer|November 30, 2022
SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?Francesca Branzoli, Betty Salgues, Małgorzata Marjańska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2026
18F-DOPA-PET and advanced MRI improve treatment response assessment in IDH1/2-mutant gliomas treated with IDH inhibitorsDiego Prost, Lucia Nichelli, Laura Rozenblum, et al.
Pageof 4